SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs about disclosure

15 Apr 2025 Evaluate
AstraZeneca Pharma India has informed that AstraZeneca Pharma India had vide its letter dated November 21, 2023, informed the receipt of Marketing Authorisation dated November 17, 2023 for Olaparib film-coated tablets 100mg and 150mg (Lynparza) which was indicated in combination with Abiraterone and Prednisone or Prednisolone for the treatment of adult patients with metastatic castration-resistant prostate cancer. Through this letter, informed that the Company has now surrendered the marketing authorisation of the above-mentioned indication of Olaparib (Lynparza) 100mg and 150mg. Also confirmed that since the date of receipt of Marketing authorisation for the said indications, November 17, 2023, till date, it has never marketed the said indication in India. the discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons. Further, informed that it continue to hold all other existing permissions for the said drug Olaparib in India.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8508.80 -16.30 (-0.19%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×